|
| Status |
Public on Mar 18, 2015 |
| Title |
Novel HDAC inhibitors exhibit pre-clinical efficacy in lymphoma models and point to the importance of CDKN1A expression levels in mediating their anti-tumor response |
| Organism |
Homo sapiens |
| Experiment type |
Expression profiling by array
|
| Summary |
investigate the pre-clinical activities of two novel histone deacetylase inhibitors (HDACi), ITF-A and ITF-B, in a large panel of pre-clinical lymphoma models
|
| |
|
| Overall design |
GEP analysis of 2 lymphoma cell lines with and without treatment
|
| |
|
| Contributor(s) |
Mensah AA, Kwee I, Gaudio E, Rinaldi A, Bertoni F |
| Citation(s) |
25671298 |
| |
| Submission date |
Jan 09, 2015 |
| Last update date |
Aug 13, 2018 |
| Contact name |
Francesco Bertoni |
| E-mail(s) |
[email protected]
|
| Phone |
+41 91 820 0367
|
| Organization name |
IOR
|
| Department |
Lymphoma & Genomics Research Program
|
| Street address |
Via V. Vela 6
|
| City |
Bellinzona |
| State/province |
Ticino |
| ZIP/Postal code |
6500 |
| Country |
Switzerland |
| |
|
| Platforms (1) |
| GPL10558 |
Illumina HumanHT-12 V4.0 expression beadchip |
|
| Samples (24)
|
|
| Relations |
| BioProject |
PRJNA271950 |
Less...
More...